LDL-C TARGET ACHIEVEMENT AND ASSOCIATED FACTORS IN VERY HIGH CARDIOVASCULAR RISK PATIENTS WITH TYPE 2 DIABETES MELLITUS IN CAN THO UNIVERSITY OF MEDICINE AND PHARMACY HOSPITAL IN 2023-2024

Le Gia Bao Huynh1,, Van Truyen Ngo1, Huu Hen Phan2
1 Can Tho University of Medicine and Pharmacy
2 Cho Ray Hospital

Main Article Content

Abstract

Background: Dyslipidemia often occurs in diabetic patients but the treatment rate is often low, especially in the very high-risk patient group according to the Guidelines of the European Society of Cardiology (ESC) in 2021. Objectives: To determine the rate of achieving LDL-c goals in very high-risk patients with type 2 diabetes mellitus. Materials and methods: A cross-sectional study on 45 very high-risk patients with type 2 diabetes mellitus was examined at Can Tho University of Medicine and Pharmacy Hospital in 2023-2024. Results: The average LDL-c concentration in patients at the time of the study was 2.32 ± 1.04 mmol/L. The proportion of patients achieving the LDL-c target according to ESC 2021 at the time of the study was 15.6%. The proportion of nonsmoking patients who achieved the LDL-c target was 100%, which was statistically significantly higher than that of those who did not achieve the LDL-c target with 57.9%. There was a strong positive linear correlation between LDL-c and non-HDL-c concentrations with r = 0.74 and the proportion of patients achieving both LDL-c and non-HDL-c targets was statistically significantly higher than that of those who did not achieved the LDL-c target, with 57.1% compared to 5,3%. No statistically significant differences were found between age , gender, alcohol consumption, physical activity, duration of diabetes, body mass index, blood sugar level, glomerular filtration rate and albuminuria with LDL-c target achievement rate. Conclusion: The proportion of very high-risk patients with type 2 diabetes mellitus achieving the LDL-c target according to ESC 2021 is still very low. In fact, the number of patients treated with high-intensity statins in this group is still limited. Non-HDL-c is a factor related to the rate of LDL-c target achievement.

Article Details

References

1. Sun H., Saeedi P., Karuranga S., Pinkepank M., Ogurtsova K. et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Research and Clinical Practice. 2022. 183, https://doi.org/10.1016/j.diabres.2021.109119.
2. Kim S. J., Kwon O. D., Kim K. S. et al. Prevalence, awareness, treatment, and control of dyslipidemia among diabetes mellitus patients and predictors of optimal dyslipidemia control: results from the Korea National Health and Nutrition Examination Survey. Lipids in Health and Disease. 2021. 20(1), 29, https://doi.org/10.1186/s12944-021-01455-3.
3. Visseren F., Mach F., Snulders Y., Carballo D., Koskinas K., Back M., et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice: Developed by the Task
Force for cardiovascular disease prevention in clinical practice with representatives of the
European Society of Cardiology and 12 medical societies With the special contribution of the European Association of Preventive Cardiology (EAPC), Revista Española de Cardiologias. 2022. 75(5), 429, https://doi.org/10.1093/eurheartj/ehab484.
4. American Diabetes Association Professional Practice Committee. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2022. Diabetes Care. 2022. 45(1), S17-S38, https://doi.org/10.2337/dc22-S002.
5. Ray K., Haq I., Bilitou A., Manu M., Burden A., et al. Treatment gaps in the implementation of LDL cholesterol control among high- and very high-risk patients in Europe between 2020 and
2021: the multinational observational SANTORINI study. The Lancet Regional Health. 2023. 29, https://doi.org/10.1016/j.lanepe.2023. 100624.
6. Võ Thanh Hoàng, Ngô Sĩ Ngọc, Nguyễn Văn Bé Út, Điêu Thanh Hùng. Khảo sát tỷ lệ đạt mục tiêu LDL-c trên bệnh nhân nguy cơ tim mạch cao và rất cao điều trị bằng statin tối ưu tại khoa
Tim mạch-Lão học. 2022.
http://benhvientimmachangiang.vn/DesktopModules/NEWS/DinhKem/1493_15.TMLH--KsTL-dat-muc-tieu-LDL-C-tren-BN.pdf.
7. Nguyễn Thị Hoa, Nguyễn Thị Ngọc Huyền. Nồng độ Non-HDL Cholesterol ở bệnh nhân đái tháo đường tuýp 2 tại bệnh viện trường Đại học Y Dược Thái Nguyên. Tạp chí Y học Dự phòng. 2021. 31(9), 170-177, https://doi.org/10.51403/0868-2836/2021/451.
8. Vương Hữu Tiến, Lê Văn Tèo, Trần Gia Huy, Hồ Sĩ Dũng, Nguyễn Đức Công. Thực trạng kiểm soát Low-Density Lipoprotein Cholesterol huyết thanh ở người cao tuổi tại phòng khám Ban bảo vệ chăm sóc sức khỏe cán bộ tỉnh Cà Mau. Tạp chí Phát triển Khoa học và Công nghệ – Khoa học Sức khỏe. 2021. 2(2), 257-264, https://doi.org/10.32508/stdjhs.v2i2.485.
9. Võ Văn Sĩ, Trần Xuân Trường, Võ Thành Duy, Nguyễn Thị Thu Thuỷ, Phạm Trương Mỹ Dung và cộng sự. Tỉ lệ đạt mục tiêu LDL Cholesterol theo khuyến cáo của Hội Tim mạch Châu Âu 2019 trên bệnh nhân có nguy cơ tim mạch cao và rất cao. Tạp Chí Y học Cộng đồng. 2022. 63(4), https://doi.org/10.52163/yhc.v63i4.368.
10. Yun S. J., Jeong I. K., Cha J. H., Lee J., Cho H. C., et al. Current Status of Low-Density Lipoprotein Cholesterol Target Achievement in Patients with Type 2 Diabetes Mellitus in Korea Compared with Recent Guidelines. Diabetes & Metabolism Journal. 2022. 46(3), 464–475, https://doi.org/10.4093/dmj.2021.0088.
11. Srinivasa R. C., Emmanuel S. Y. The Effect of Chronic Tobacco Smoking and Chewing on the Lipid Profile. Journal of Clinical and Diagnostic Research. 2013. 7(1), 31–34, https://doi.org/10.7860/JCDR/2012/5086.2663.
12. Nguyễn Văn Sĩ, Đinh Quốc Bảo. Kiểm soát non-HDL-c sau khi đạt mục tiêu LDL-c trên người bệnh đái tháo đường type 2 điều trị ngoại trú. Tạp chí Y học Việt Nam. 2024. 537(1), https://doi.org/10.51298/vmj.v537i1.9061.